Hypoxia alters cell cycle regulatory protein expression and induces premature maturation of oligodendrocyte precursor cells

PLoS ONE

Volumn 4, Issue 3, 2009, Pages

  Akundi, Ravi Shankar ^a   Rivkees, Scott A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MYELIN BASIC PROTEIN; OXYGEN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; VASCULOTROPIN A; BROXURIDINE; CDC2 PROTEIN, HUMAN; CYCLIN B; DIAGNOSTIC AGENT; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR A; PLATELET-DERIVED GROWTH FACTOR A;

ANIMAL CELL; ARTICLE; BRAIN INJURY; CELL CULTURE; CELL CYCLE REGULATION; CELL DEATH; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; GLIA CELL; HYPOXIA; IN VITRO STUDY; NONHUMAN; OLIGODENDROCYTE PRECURSOR CELL; OLIGODENDROGLIA; PERIVENTRICULAR WHITE MATTER INJURY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; STEM CELL; WHITE MATTER; ANIMAL; ANOXIA; BRAIN; CYTOLOGY; ENZYME IMMUNOASSAY; METABOLISM; NEWBORN; PHOSPHORYLATION; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; ANOXIA; BLOTTING, WESTERN; BRAIN; BROMODEOXYURIDINE; CELLS, CULTURED; CYCLIN B; CYCLIN-DEPENDENT KINASE INHIBITOR P27; IMMUNOENZYME TECHNIQUES; OLIGODENDROGLIA; PHOSPHORYLATION; PLATELET-DERIVED GROWTH FACTOR; RATS;

EID: 62749176461     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0004739     Document Type: Article

References (38)

1. Rezaie P, Dean A (2002) Periventricular leukomalacia, inflammation and white matter lesions within the developing nervous system. Neuropathology 22: 106-132.
2. Ment LR, Schwartz M, Makuch RW, Stewart WB (1998) Association of chronic sublethal hypoxia with ventriculomegaly in the developing rat brain. Brain Research Developmental Brain Research 111: 197-203.
3. Back SA, Volpe JJ (1997) Cellular and molecular pathogenesis of periventricular white matter injury. MRDD Res Rev 3: 96-107.
4. Back SA (2001) Approaches to the cellular and molecular pathogenesis of human perinatal white matter injury. In: Choi D, Dacey Jr R, Hsu CH, Powers W, eds. Cerebrovascular disease: Momentum at the end of the second millenium (21st Princeton Conference). Armonk, New York: Futura Press. pp 131-160.
5. Pfeiffer SE, Warrington AE, Bansal R (1993) The oligodendrocyte and its many cellular processes. Trends Cell Biol 3: 191-197.
6. de Castro F, Bribian A (2005) The molecular orchestra of the migration of oligodendrocyte precursors during development. Brain Res Brain Res Rev 49: 227-241.
7. Craig A, Luo NL, Beardsley DJ, Wingate-Pearse N, Walker DW, et al. (2003) Quantitative analysis of rodent oligodendrocyte lineage progression and its correlation with human. Exp Neurol 181.
8. Gard AL, Pfeiffer SE (1990) Two proliferative stages of the oligodendrocyte lineage (A2B5+O4- and O4+GalC-) under different mitogenic control. Neuron 5: 615-625.
9. Warrington AE, Barbarese E, Pfeiffer SE (1992) Stage specific, (O4+GalC-) isolated oligodendrocyte progenitors produce MBP+ myelin in vivo. Dev Neurosci 14: 93-97.
10. Bansal R, Warrington AE, Gard AL, Ranscht B, Pfeiffer SE (1989) Multiple and novel specificities of monoclonal antibodies O1, O4, and R-mAb used in the analysis of oligodendrocyte development. J Neurosci Res 24: 548-557.
11. Baron W, Metz B, Bansal R, Hoekstra D, de Vries H (2000) PDGF and FGF-2 signaling in oligodendrocyte progenitor cells: regulation of proliferation and differentiation by multiple intracellular signaling pathways. Mol Cell Neurosci 15: 314-329.
12. Gard AL, Pfeiffer SE, Williams WC III (1993) Immunopanning and developmental stage-specific primary culture of oligodendrocyte progenitors (O4+GalC-) directly from postnatal rodent cerebrum. Neuroprotocols 2: 209-218.
13. Raff MC, Lillien LE, Richardson WD, Burne JF, Noble MD (1988) Platelet-derived growth factor from astrocytes drives the clock that times oligodendrocyte development in culture. Nature 333: 562-565.
14. Casaccia-Bonnefil P, Liu A (2003) Relationship between cell cycle molecules and onset of oligodendrocyte differentiation. J Neurosci Res 72: 1-11.
15. Sherr CJ (1996) Cancer cell cycles. Science 274: 1672-1677.
16. Raff M, Apperly J, Kondo T, Tokumoto Y, Tang D (2001) Timing cell-cycle exit and differentiation in oligodendrocyte development. Novartis Found Symp 237: 100-107; discussion 107-112, 158-163.
17. Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81: 323-330.
18. Nigg EA, Gallant P, Krek W (1992) Regulation of p34cdc2 protein kinase activity by phosphorylation and cyclin binding. Ciba Found Symp 170: 72-84; discussion 84-96.
19. Stark GR, Taylor WR (2004) Analyzing the G2/M checkpoint. Methods Mol Biol 280: 51-82.
20. Casaccia-Bonnefil P, Tikoo R, Kiyokawa H, Friedrich VJ, Chao M, et al. (1997) Oligodendrocyte precursor differentiation is perturbed in the absence of the cyclin-dependent kinase inhibitor p27Kip1. Genes Dev 11: 2335-2346.
21. Bansal R, Marin-Husstege M, Bryant M, Casaccia-Bonnefil P (2005) S-phase entry of oligodendrocyte lineage cells is associated with increased levels of p21Cip1. J Neurosci Res 80: 360-368.
22. McCarthy KD, de Vellis J (1980) Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85: 890-902.
23. Springer T, Galfre G, Secher DS, Milstein C (1979) Mac-1: a macrophage differentiation antigen identified by monoclonal antibody. Eur J Immunol 9: 301-306.
24. Goebel HH, Schlie M, Eng LF (1987) Immunohistopathologic spectrum of the glial fibrillary acidic protein in neurooncology. Acta Histochem Suppl 34: 81-93.
25. Yan H, Rivkees SA (2002) Hepatocyte growth factor stimulates the proliferation and migration of oligodendrocyte precursor cells. J Neurosci Res 69: 597-606.
26. Jones LJ, Gray M, Yue ST, Haugland RP, Singer VL (2001) Sensitive determination of cell number using the CyQUANT cell proliferation assay. J Immunol Methods 254: 85-98.
27. Arteel GE, Thurman RG, Yates JM, Raleigh JA (1995) Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver. Br J Cancer 72: 889-895.
28. Faulstich H, Zobeley S, Rinnerthaler G, Small JV (1988) Fluorescent phallotoxins as probes for filamentous actin. J Muscle Res Cell Motil 9: 370-383.
29. Wendler CC, Amatya S, McClaskey C, Ghatpande S, Fredholm BB, et al. (2007) A1 adenosine receptors play an essential role in protecting the embryo against hypoxia. Proc Natl Acad Sci U S A 104: 9697-9702.
30. Resnik ER, Herron JM, Lyu SC, Cornfield DN (2007) Developmental regulation of hypoxia-inducible factor 1 and prolyl-hydroxylases in pulmonary vascular smooth muscle cells. Proc Natl Acad Sci U S A 104: 18789-18794.
31. Bogler O, Wren D, Barnett SC, Land H, Noble M (1990) Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte(O-2A) progenitor cells. Proc Natl Acad Sci USA 87: 6368-6372.
32. Papadopoulos NG, Dedoussis GV, Spanakos G, Gritzapis AD, Baxevanis CN, et al. (1994) An improved fluorescence assay for the determination of lymphocyte-mediated cytotoxicity using flow cytometry. J Immunol Methods 177: 101-111.
33. Back SA (2006) Perinatal white matter injury: the changing spectrum of pathology and emerging insights into pathogenetic mechanisms. Ment Retard Dev Disabil Res Rev 12: 129-140.
34. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, et al. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16: 4604-4613.
35. Yan H, Rivkees SA (2005) Hypoglycemia influences oligodendrocyte development and myelin formation. NeuroReport (in press).
36. Sherr CJ, Roberts JM (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13: 1501-1512.
37. Li S, Chen BP, Azuma N, Hu YL, Wu SZ, et al. (1999) Distinct roles for the small GTPases Cdc42 and Rho in endothelial responses to shear stress. J Clin Invest 103: 1141-1150.
38. Casaccia-Bonnefil P, Hardy RJ, Teng KK, Levine JM, Koff A, et al. (1999) Loss of p27Kip1 function results in increased proliferative capacity of oligodendrocyte progenitors but unaltered timing of differentiation. Development 126: 4027-4037.